Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:55 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 524394 | NSE: VIMTALABS

Vimta Labs Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹348.36Overvalued by 14.62%vs CMP ₹408.00

P/E (24.0) × ROE (19.4%) × BV (₹93.30) × DY (0.24%)

₹223.79Overvalued by 45.15%vs CMP ₹408.00
MoS: -82.3% (Negative)Confidence: 63/100 (Moderate)Models: 1 Fair, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹392.0423%Fair (-3.9%)
Graham NumberEarnings₹187.6316%Over (-54%)
Earnings PowerEarnings₹90.4411%Over (-77.8%)
DCFCash Flow₹307.1014%Over (-24.7%)
Net Asset ValueAssets₹93.107%Over (-77.2%)
EV/EBITDAEnterprise₹279.539%Over (-31.5%)
Earnings YieldEarnings₹167.707%Over (-58.9%)
ROCE CapitalReturns₹50.417%Over (-87.6%)
Revenue MultipleRevenue₹76.995%Over (-81.1%)
Consensus (9 models)₹223.79100%Overvalued
Key Drivers: Wide model spread (₹50–₹392) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 12.5%

*Investments are subject to market risks

Investment Snapshot

75
Vimta Labs Ltd scores 75/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health92/100 · Strong
ROCE 25.2% ExcellentROE 19.4% ExcellentD/E 0.13 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding up 0.93% (6mo) Slight increaseDII holding down 1.32% MF sellingPromoter holding at 35.9% Stable
Earnings Quality65/100 · Strong
OPM expanding (30% → 34%) Improving
Quarterly Momentum78/100 · Strong
Revenue (4Q): +22% YoY AcceleratingProfit (4Q): +23% YoY Positive
Industry Rank70/100 · Strong
P/E 24.0 vs industry 34.3 In-lineROCE 25.2% vs industry 17.2% Above peersROE 19.4% vs industry 13.0% Above peers3Y sales CAGR: 8% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:55 am

Market Cap 1,823 Cr.
Current Price 408
Intrinsic Value₹223.79
High / Low 903/372
Stock P/E24.0
Book Value 93.3
Dividend Yield0.24 %
ROCE25.2 %
ROE19.4 %
Face Value 2.00
PEG Ratio1.91

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Vimta Labs Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Vimta Labs Ltd 1,823 Cr. 408 903/37224.0 93.30.24 %25.2 %19.4 % 2.00
Choksi Laboratories Ltd 70.7 Cr. 102 237/81.844.5 35.20.00 %9.20 %6.63 % 10.0
Industry Average1,823.00 Cr255.0034.2564.250.12%17.20%13.02%6.00

All Competitor Stocks of Vimta Labs Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 768182647373758590949810299
Expenses 55575848504749555761646864
Operating Profit 21242417232626303333343434
OPM % 27%29%29%26%31%36%35%35%37%35%35%34%35%
Other Income 1110-1-1-1-152230
Interest 1001110010000
Depreciation 88898888109101011
Profit before tax 1416168131617202825252623
Tax % 27%23%25%25%25%24%26%24%23%27%25%24%25%
Net Profit 101212691212152218192018
EPS in Rs 2.252.772.631.342.142.792.773.444.844.124.244.473.94

Last Updated: February 3, 2026, 3:46 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 9:46 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 127116138154183213181209276315289344392
Expenses 10199119127138155151156196222195222257
Operating Profit 2617192745583053809494122135
OPM % 20%15%14%18%25%27%17%25%29%30%33%35%34%
Other Income 3111123103-456
Interest 2112554223221
Depreciation 9111010162021232331333540
Profit before tax 187817263582855645590100
Tax % 25%24%23%36%36%28%17%25%26%26%25%25%
Net Profit 13561116257214147416775
EPS in Rs 3.001.141.452.403.725.731.574.819.2910.689.2615.1316.77
Dividend Payout % 33%44%34%0%27%17%0%21%11%9%11%7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-61.54%20.00%83.33%45.45%56.25%-72.00%200.00%95.24%14.63%-12.77%63.41%
Change in YoY Net Profit Growth (%)0.00%81.54%63.33%-37.88%10.80%-128.25%272.00%-104.76%-80.60%-27.40%76.18%

Vimta Labs Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:14%
3 Years:8%
TTM:28%
Compounded Profit Growth
10 Years:30%
5 Years:58%
3 Years:17%
TTM:51%
Stock Price CAGR
10 Years:38%
5 Years:72%
3 Years:65%
1 Year:146%
Return on Equity
10 Years:14%
5 Years:17%
3 Years:17%
Last Year:19%

Last Updated: September 5, 2025, 1:51 pm

Balance Sheet

Last Updated: February 1, 2026, 4:08 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 4444444444449
Reserves 116118122132148167169190229276310374407
Borrowings 7426444026323019151997
Other Liabilities 22212342404039495465617995
Total Liabilities 149146176222232237245273306360394467518
Fixed Assets 90888888140135131128162168166230240
CWIP 2065304217012593855
Investments 0000006666000
Other Assets 575882809299105122138174170198224
Total Assets 149146176222232237245273306360394467518

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 1715-1243339243759876195
Cash from Investing Activity + -8-8-16-39-24-16-20-32-38-57-76-76
Cash from Financing Activity + -8-91913-8-23-1-5-16-11-2-17
Net Cash Flow 0-12-21131519-172
Free Cash Flow 98-17-169231052037-1418
CFO/OP 79%96%4%107%86%85%101%84%94%106%81%96%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow19.0013.00-7.00-17.005.0032.00-2.0023.0061.0079.0075.00113.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 818210010111110011712810293110113
Inventory Days 175158213183209199191140154195260210
Days Payable 8766771841481151141391081248788
Cash Conversion Cycle 169174236100172184194128147164283235
Working Capital Days 6510999226278648987789896
ROCE %16%6%7%11%17%21%6%14%24%24%20%25%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 37.25%37.23%37.00%36.98%36.92%36.89%36.89%36.76%36.70%36.67%35.99%35.89%
FIIs 2.25%2.72%2.74%2.88%5.13%5.16%3.31%3.81%3.66%3.49%4.33%4.59%
DIIs 2.14%2.14%1.50%1.49%1.50%1.49%0.00%1.15%1.43%1.42%0.87%0.11%
Public 58.37%57.92%58.75%58.65%56.45%56.45%59.80%58.28%58.20%58.42%58.80%59.40%
No. of Shareholders 17,16217,43918,42919,95718,55019,05420,11421,15626,18330,82955,93354,467

Shareholding Pattern Chart

No. of Shareholders

Vimta Labs Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund 330,152 0.1 14.99330,1522025-04-22 17:25:160%
Motilal Oswal S&P BSE Healthcare ETF 78 0.04 0782025-04-22 17:25:160%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 18.5121.7718.709.683.10
Diluted EPS (Rs.) 18.2421.3518.329.683.10
Cash EPS (Rs.) 33.9235.6529.2420.1212.56
Book Value[Excl.RevalReserv]/Share (Rs.) 144.20127.33105.8387.9278.19
Book Value[Incl.RevalReserv]/Share (Rs.) 144.20127.33105.8387.9278.19
Revenue From Operations / Share (Rs.) 143.55143.78125.8695.2981.73
PBDIT / Share (Rs.) 40.9644.4436.9724.3314.91
PBIT / Share (Rs.) 25.5330.5726.4213.895.44
PBT / Share (Rs.) 24.5729.3725.1912.913.74
Net Profit / Share (Rs.) 18.5021.7718.699.683.10
NP After MI And SOA / Share (Rs.) 18.5021.7718.699.683.10
PBDIT Margin (%) 28.5230.9129.3725.5218.24
PBIT Margin (%) 17.7821.2520.9814.576.65
PBT Margin (%) 17.1120.4220.0113.544.57
Net Profit Margin (%) 12.8815.1314.8510.163.78
NP After MI And SOA Margin (%) 12.8815.1314.8510.163.78
Return on Networth / Equity (%) 12.8217.0917.6611.013.95
Return on Capital Employeed (%) 16.3622.1722.5113.926.39
Return On Assets (%) 10.2513.2913.457.802.78
Long Term Debt / Equity (X) 0.020.030.050.070.03
Total Debt / Equity (X) 0.060.050.080.110.13
Asset Turnover Ratio (%) 0.830.950.950.810.00
Current Ratio (X) 2.912.862.602.051.67
Quick Ratio (X) 2.462.462.241.781.37
Dividend Payout Ratio (NP) (%) 10.799.1710.690.0064.60
Dividend Payout Ratio (CP) (%) 5.885.606.830.0015.91
Earning Retention Ratio (%) 89.2190.8389.310.0035.40
Cash Earning Retention Ratio (%) 94.1294.4093.170.0084.09
Interest Coverage Ratio (X) 42.7937.1954.5624.818.76
Interest Coverage Ratio (Post Tax) (X) 20.3319.2129.4110.872.82
Enterprise Value (Cr.) 979.08670.65704.61372.30147.42
EV / Net Operating Revenue (X) 3.082.112.531.770.81
EV / EBITDA (X) 10.786.828.626.924.47
MarketCap / Net Operating Revenue (X) 3.102.192.501.690.72
Retention Ratios (%) 89.2090.8289.300.0035.39
Price / BV (X) 3.082.472.981.830.75
Price / Net Operating Revenue (X) 3.102.192.501.690.72
EarningsYield 0.040.060.050.060.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977. Currently company belongs to the Industry of Medical Research Services. Company's Total Operating Revenue is Rs. 343.98 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Medical Research ServicesPlot Nos. 141/2 & 142, Hyderabad Telangana 500051Contact not found
Management
NamePosition Held
Dr. Sivalinga Prasad VasireddiExecutive Chairman
Ms. Harita VasireddiManaging Director
Mr. Harriman VungalExecutive Director - Operations
Mr. Satya Sreenivas NeerukondaExecutive Director
Dr. Yadagiri R PendriIndependent Director
Ms. Prameela Rani YalamanchiliIndependent Director
Mr. Sanjay DaveIndependent Director
Mr. Purnachandra Rao GuttaIndependent Director

FAQ

What is the intrinsic value of Vimta Labs Ltd and is it undervalued?

As of 17 April 2026, Vimta Labs Ltd's intrinsic value is ₹223.79, which is 45.15% lower than the current market price of ₹408.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (19.4 %), book value (₹93.3), dividend yield (0.24 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Vimta Labs Ltd?

Vimta Labs Ltd is trading at ₹408.00 as of 17 April 2026, with a FY2026-2027 high of ₹903 and low of ₹372. The stock is currently near its 52-week low. Market cap stands at ₹1,823 Cr..

How does Vimta Labs Ltd's P/E ratio compare to its industry?

Vimta Labs Ltd has a P/E ratio of 24.0, which is below the industry average of 34.25. This is broadly in line with or below the industry average.

Is Vimta Labs Ltd financially healthy?

Key indicators for Vimta Labs Ltd: ROCE of 25.2 % indicates efficient capital utilization; ROE of 19.4 % shows strong shareholder returns. Dividend yield is 0.24 %.

Is Vimta Labs Ltd profitable and how is the profit trend?

Vimta Labs Ltd reported a net profit of ₹67 Cr in Mar 2025 on revenue of ₹344 Cr. Compared to ₹41 Cr in Mar 2022, the net profit shows an improving trend.

Does Vimta Labs Ltd pay dividends?

Vimta Labs Ltd has a dividend yield of 0.24 % at the current price of ₹408.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Vimta Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports